abnormalities and ovarian dysgenesis (Turner, 1938; Ford et al., 1958; Hook and Warburton, 1983 , 1992). According to other reports, where the outcome higher in the subsequent than initial cycles (22.6 versus of oocyte donation in Turner's syndrome was assessed, the 9.99%, P Ͻ0.05; 51.3 versus 27.6%, P Ͻ0.05). An endometfindings were contradictory with one reporting lower pregnancy rial thickness of ജ6.5 mm was an important predictor of rates (Heinze, 1994) while another suggested better results in pregnancy but the endometrial echo pattern failed to comparison with other indications (Abdalla et al., 1990) . When predict the outcome. Although the total dose of oestradiol the outcome of oocyte donation in Turner's syndrome was before embryo transfer was higher in the pregnant cycles compared with that in women with premature menopause the than the non-pregnant ones and its gradation (Ͻ50 mg, results from the two groups were similar (Press et al., 1995). 50-100 mg, Ͻ100 mg) influenced the implantation (3.4, With such inconsistencies in previous reports, there is a 17.5, 26.3% respectively, P Ͻ0.05) and pregnancy rates need for further assessment of results and the factors influencing (10, 42.2, 61.5% respectively, P Ͻ0.05), the effect was outcome of oocyte donation in a larger population of patients indirect by altering the endometrial thickness. The number with Turner's syndrome. This is particularly important because of oocytes fertilized affected the pregnancy rate irrespective the endometrial response to hormone replacement has been of the number of embryos transferred. The implantation reported to be suboptimum in this special category compared and pregnancy rates were higher when fresh rather than with the other causes of premature ovarian failure (Davies frozen-thawed embryos were transferred (20. 3 versus et al., 1990; Li et al., 1991). There may also be difficulties in 8.2%, P Ͻ0.05; 48 versus 22.2%, P Ͻ0.05) but the route embryo transfer due to associated hypoplasia and malformation of transfer was of no statistical importance. The overall of the genital tract. In terms of pregnancy outcome it would miscarriage rate was higher (50%), and was related to the be interesting to know whether the increased incidence of presence of hypoplastic or bicornuate uterus and to a low miscarriage continues with the use of donor oocytes. This oocyte fertilization rate.
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women with this condition have streak ovaries with the absence Fertility and Endocrinology Centre, Lister Hospital, Chelsea Bridge of any follicular structure. However, occasionally there may Road, London SW1W 8RH, UK be a few follicles in the ovaries that are able to induce 1 To whom correspondence should be addressed menstrual periods for some time before the onset of a premature menopause (Groll and Cooper, 1976 ; Rosenfield and Grum-A total of 29 women with Turner's syndrome (19 monosomy back, 1990; Lippe, 1991) . Thus, chances of spontaneous and 10 mosaic) had 68 cycles of oocyte donation that pregnancy are extremely rare in Turner's syndrome, irrespectincluded 29 cycles of initial attempt and 39 cycles of ive of the karyotype. Since the first publication by Bahner subsequent attempts. Oral oestradiol valerate was used et al. (1960) , only sporadic pregnancies have been reported either in a variable dose (42 cycles) or in a constant dose from patients with either homogeneous 45XO or mosaic (26 cycles) regimen for the endometrial preparation which 45XO/46XX chromosomal constitutions. The outcome of these was monitored by pelvic ultrasonography. The embryos/ pregnancies was poor with an increased incidence of miscarzygotes were transferred either fresh (50 cycles) or after riage and stillbirths (Dewhurst, 1978; King et al., 1978 ; Nielson cryopreservation (18 cycles) into the Fallopian tube (41 et al., 1979; Wray et al., 1981; Kaneko et al., 1990) . cycles) and uterine cavity (27 cycles) as appropriate. There
Oocyte donation treatment for women with Turner's synwere 28 clinical pregnancies including two sets of triplets drome is expected to offer a better chance of conceiving with resulting in a pregnancy rate of 41.2% per treatment cycle less pregnancy wastage. A few cases of Turner's syndrome and an implantation rate of 17.1% per embryo transferred.
have been mentioned in many reports of oocyte donation but The recipient's age, chromosomal constitution or associated their outcomes were not analysed separately (Devroey et al., uterine 
or tubal anomaly had no influence on the treatment
1988; Salat-Baroux et al., 1988; Abdalla et al., 1989 ; Pados outcome. The implantation and pregnancy rates were et al., 1992) . According to other reports, where the outcome higher in the subsequent than initial cycles (22.6 versus of oocyte donation in Turner's syndrome was assessed, the 9.99%, P Ͻ0.05; 51.3 versus 27.6%, P Ͻ0.05). An endometfindings were contradictory with one reporting lower pregnancy rial thickness of ജ6.5 mm was an important predictor of rates (Heinze, 1994) while another suggested better results in pregnancy but the endometrial echo pattern failed to comparison with other indications (Abdalla et al., 1990) . When predict the outcome. Although the total dose of oestradiol the outcome of oocyte donation in Turner's syndrome was before embryo transfer was higher in the pregnant cycles compared with that in women with premature menopause the than the non-pregnant ones and its gradation (Ͻ50 mg, results from the two groups were similar (Press et al., 1995) . 50-100 mg, Ͻ100 mg) influenced the implantation (3.4, With such inconsistencies in previous reports, there is a 17.5, 26.3% respectively, P Ͻ0.05) and pregnancy rates need for further assessment of results and the factors influencing (10, 42.2, 61.5% respectively, P Ͻ0.05), the effect was outcome of oocyte donation in a larger population of patients indirect by altering the endometrial thickness. The number with Turner's syndrome. This is particularly important because of oocytes fertilized affected the pregnancy rate irrespective the endometrial response to hormone replacement has been of the number of embryos transferred. The implantation reported to be suboptimum in this special category compared and pregnancy rates were higher when fresh rather than with the other causes of premature ovarian failure (Davies frozen-thawed embryos were transferred (20. 3 versus et al., 1990; Li et al., 1991) . There may also be difficulties in 8.2%, P Ͻ0.05; 48 versus 22.2%, P Ͻ0.05) but the route embryo transfer due to associated hypoplasia and malformation of transfer was of no statistical importance. The overall of the genital tract. In terms of pregnancy outcome it would miscarriage rate was higher (50%), and was related to the be interesting to know whether the increased incidence of presence of hypoplastic or bicornuate uterus and to a low miscarriage continues with the use of donor oocytes. This oocyte fertilization rate.
would determine whether an abnormal uterine factor or oocyte Key words: donor oocyte/outcome/Turner's syndrome chromosomal aberration is the cause of increased pregnancy wastage.
We report on what is, to date, the largest series of oocyte Introduction donation treatment in women with Turner's syndrome. The purpose of the study was to assess the reproductive potential Turner's syndrome is characterized by the complete or partial absence of one X chromosome that results in multiple somatic of these women in terms of their endometrial response to 
Materials and methods
patterns were expressed as their density relative to that of the Oocyte recipients anterior wall of the myometrium and were accordingly categorized A total of 29 women with Turner's syndrome whose mean (ϮSD) as hypoechoic, isoechoic and hyperechoic. All ultrasonographies were age was 30.24 Ϯ 4.35 years (range 23-40), had 68 cycles of oocyte performed by a single observer using one machine to minimize the donation treatment between January 1988 and December 1995. The subjective variation. The endometrial echo pattern on the day before chromosomal constitutions were 45X (monosomy) in 19 and 45X/ progesterone administration (day of donor's HCG injection) and 46XX (mosaic) in the remaining 10 women. The two groups of endometrial thickness on the day of embryo transfer were compared women had 52 and 16 cycles of oocyte donation respectively. Only between different groups and their outcomes. four of these women had spontaneous menstruation in the past and Oocyte donation, fertilization and embryo transfer none had any prior spontaneous conceptions. At the time of treatment all women had gonadotrophin concentrations of Ͼ20 IU/l and The oocytes were donated anonymously by 57 healthy women whose were experiencing artificial menstrual cycles from administration of mean (ϮSD) age was 29.67 Ϯ 4.14 years (range 23-38); 49 (86%) oestradiol valerate 2 mg daily for 11 days together with norgestrel of them were parous. The mean (ϮSD) number of oocytes obtained 0.5 mg daily for a further 10 days every month (Cycloprogynova per donation was 10.93 Ϯ 4.99 (range 2-21) which were usually 2 mg; Schering, Burgess Hill, West Sussex, UK) while on the waiting divided between two recipients in the oocyte donation programme so list for oocyte donation.
that the mean (ϮSD) number of oocytes per recipient was 5.5 Ϯ 1.8 A pre-treatment assessment of these women by hysterosalpingogra-(range 2-11). The mean (ϮSD) number of oocytes fertilized was phy and/or laparoscopy revealed abnormalities including hypoplastic 3.93 Ϯ 2.05 (range 1-11) from which the mean (ϮSD) number of uterus and tubes (n ϭ 7), bicornuate uterus (n ϭ 4) and blocked embryos/zygotes transferred was 2.75 Ϯ 0.76 (range 1-5; maximum of tubes (n ϭ 4). Women with hypoplastic and bicornuate uteri had 14 three after August 1991). The embryos/zygotes were either transferred and 5 treatment cycles respectively. Associated infertility causes were fresh in 50 cycles (73.5%) or after cryopreservation in 18 cycles present in six couples: a tubal factor was present in four women who (26.5%). The route of transfer was tubal in 41 cycles (60.3%), which had 13 cycles and a male factor was noted in two couples who had comprised zygote intra-Fallopian transfer (ZIFT) in the fresh cycles four cycles of oocyte donation. Some patients had more than one but tubal embryo transfer (TET) in the frozen cycles, and uterine in pelvic anomaly. In the remaining 23 couples, ovarian failure was the the remaining 27 cycles (39.7%). The choice of route was preferenonly cause of infertility and they received 51 cycles of treatment. All tially tubal unless restricted by an unsuitable tubal status (n ϭ 13), women experienced at least one attempt which comprised the group fewer numbers of embryos available (n ϭ 3), unfavourable experiences of 29 initial treatment cycles (42.6%). The remaining 39 subsequent from a previous tubal transfer (n ϭ 6) or patient's choice regarding cycles (57.4%) were the second (n ϭ 9), third (n ϭ 8), fourth (n ϭ anaesthesia (n ϭ 5). The uterine embryo transfers were not difficult 6) and fifth (n ϭ 2) attempts, and one patient continued till the ninth even in patients with hypoplastic uterus and none required general attempt before she had a successful outcome.
anaesthesia. Following embryo/zygote transfer all recipients continued to receive oestradiol and progesterone replacement for another 2 Hormone replacement weeks. Pregnancy tests were then performed and, if positive, the hormone replacement was extended until 12 weeks of gestation. The The endometrial preparation for implantation was induced by either diagnosis of a positive pregnancy was confirmed by a pelvic ultrasound variable (Lutjen et al., 1984; Abdalla et al., 1990) or constant (Serhal scan at 5 weeks to locate the gestational sac. and Craft, 1987) doses of oral oestradiol valerate (Progynova; Schering). With the variable dose regimen (42 cycles) the recipients Statistical analysis received 2 mg oestradiol valerate daily from the beginning of their menstrual cycles and after the onset of the donor's periods the dose
The influence of different patient characteristics and treatment variables on the outcome of oocyte donation were estimated. The patients was increased to 4 mg daily. When the donor was at the appropriate stage to receive human chorionic gonadotrophin (HCG; 10 000 IU), were therefore grouped according to their age (in 5 year intervals), chromosomal constitution, uterine and tubal status, the sequence of the dose of oestradiol valerate to the recipient was further increased to 6 mg and micronized progesterone vaginal pessaries 300 mg treatment cycle, the hormone replacement therapy (HRT) regimen, total dose and duration of oestrogen replacement, endometrial thick-(Utrogestan; Kingston 2000 Group, UK) were given daily from the day prior to oocyte retrieval. Recipients on the constant dose regimen ness and echo pattern, number and type of embryos, and their mode of transfer. The implantation and pregnancy rates were compared (26 cycles) received 6 mg oestradiol valerate daily from the early part of their menstrual cycle and continued on the same dose after between these subgroups to assess the influence of these factors on the outcome. The statistical analysis was carried out by the χ 2 test administration of progesterone pessaries. The selection of oestrogen regimen for the initial attempt was predominantly variable (22 cycles) with Yates' correction or Fisher's exact test as appropriate for the comparison of incidence and by the Mann-Whitney U-test for except in patients with hypoplastic uterus where a constant regimen that gave a higher total dose of oestrogen was chosen (seven cycles).
comparing the medians between two groups of patients. Since multiple variables may influence the outcome of oocyte donation it is important For the subsequent attempts the variable regimen was repeated in 20 cycles but in the remaining 19 cycles the constant regimen was to establish the effect of an individual factor without it being confounded by others. Many of these variables are also interrelated, substituted, due to poor endometrial response in the initial cycle. The duration and total amount of oestrogen administered until the day for example, the total dose of oestrogen is dependent upon the hormone replacement regimen and the duration of replacement. The before the embryo transfer were recorded. 30%; P Ͻ0.05). The number of constant oestrogen regimen were not different between pregnant and non-pregnant cycles.
Number of oocytes donated 13 (2-21) 11 (4-18) Number of donor oocytes 7 (2-11) 6 (3-11)
The donor age and parity, number of oocytes donated and received number of oocytes received were similar in the pregnant and cycles there were no statistically significant differences either
in the proportion of cycles using fresh (85.7 versus 65%) or frozen embryos (14.3 versus 35%) or in the route of embryo transfer be it tubal (46.4 versus 35%) or uterine (53.6 versus outcome of oocyte donation is binomial (either pregnant or non-65%).
pregnant), and subsequently, either miscarried or not. A logistic
When the implantation and pregnancy rates were assessed regression analysis was, therefore, performed to assess the effects of individually in different age groups, according to the chromoindividual factors in a stepwise fashion so that their relative contributions to the outcome could be determined.
somal constitutions and with varied pelvic anomalies there were no statistically significant differences between the groups (Table II) . The male factor patients did not have any effect on Results overall fertilization rate and were therefore included in the When the overall outcome was analysed, 17 out of the 29 study. The outcomes were better in the subsequent treatment women with Turner's syndrome undergoing oocyte donation cycles in comparison with the initial treatment cycles with treatment had clinical pregnancies confirmed by the presence both the implantation (22.6 versus 9.99%; χ 2 ϭ 4.41, P Ͻ0.05) of a gestation sac on ultrasonography. The treatment was and pregnancy rates (51.3 versus 27.6%; P Ͻ0.05). Similarly successful on one occasion in 10 women, twice in four women, the constant oestrogen regimen was superior to the variable three times in two women and one woman had success on one in rates of implantation (27.1 versus 11.1%; χ 2 ϭ 6.84, four occasions. Only one of these women who became pregnant P Ͻ0.01) and pregnancy (55.5 versus 31.7%; P Ͻ0.05). more than once had two viable pregnancies. A total of 28 However, the trend of improved outcome with the constant pregnancies resulted out of 68 treatment cycles giving a oestrogen regimen over the variable one did not reach statistical pregnancy rate of 41.2% per cycle. A single gestational sac significance when assessed separately in the initial (implantawas present in all cases, except for two pregnant women who tion rate 21 versus 6.5%; pregnancy rate: 50 versus 19%) and had triplets. Thus 32 gestational sacs developed following subsequent treatment cycles (implantation rate 31.25 versus transfer of 187 embryos giving an implantation rate of 17.1%
15.5%; pregnancy rate: 57.9 versus 45%). per embryo. Out of 28 pregnancies, eight were aborted prior
The average dose and duration of oestrogen before embryo to 8 weeks, six had spontaneous miscarriages after the detection transfer in the variable regimen is usually Ͻ50 mg and of a fetal heart beat at 8 weeks, one was tubal ectopic and the Ͻ15 days respectively. Thus the cycles using a higher dose of remaining 13 pregnancies progressed till delivery. With the oestrogen (ജ50 mg) were the ones with constant regimen or incidence of miscarriage of 50% and of ectopic pregnancy of a prolonged variable regimen. In order to assess whether the 3.5%, the take-home baby rate was 19.1% per treatment cycle. difference in outcomes with two oestrogen regimens was due The recipients' and donors' characteristics were compared to the higher daily dose rather than to the sequential increase between pregnant and non-pregnant cycles (Table I ). The over a prolonged period, the cycles were categorized either median age of the recipients, proportion of chromosomal according to the dose (Ͻ50 mg, 50-100 mg and Ͼ100 mg) subtypes, presence of associated tubal and male infertility, and or according to the duration (Ͻ15 days and ജ15 days). hypoplastic and bicornuate uterus were similar irrespective of Analysis of the former indicated that there was a dose-response the treatment outcome. In the pregnant group there was a trend difference between the three groups with a greater success towards a greater number of subsequent treatment cycles with higher dose in terms of both the implantation (3.4, 17.5, compared with the non-pregnant group but this failed to reach 26.3%; χ 2 ϭ 6.09, P Ͻ0.05) and the pregnancy rates (10, statistical significance (71.4 versus 47.5%). The number of 42.2, 61.5%; χ 2 ϭ 6.25, P Ͻ0.05). However, the treatment cycles using a constant oestrogen regimen was higher in the pregnant group than in the non-pregnant one (53.6 versus outcomes were not influenced by the duration of oestrogen outcome since implantation (14.3, 18.9, 16.6%) and pregnancy affecting the endometrial thickness. The higher pregnancy rate with the constant dose rather than the variable dose of oestradiol a The numbers add up to more than expected total as some patients had more than one pelvic anomaly.
replacement was due to the difference in the total dose in the b P Ͻ0.05 (χ 2 test).
two regimens indirectly influenced the endometrial thickness.
c P Ͻ0.01 (χ 2 test).
Logistic regression analysis showed that the high miscarriage rate was influenced by the presence of hypoplastic or bicornuate uterus and a lower number of oocytes fertilized (Table V) . replacement before embryo transfer, whether Ͻ15 days or ജ15 days (Table II) .
If a cut-off point of 6.5 mm of endometrial thickness on the Discussion day of endometrial transfer was taken to be the outcome predictor there was no implantation or pregnancy below this range, which
With oocyte donation the chances of conception and delivery of a healthy baby have become a reality for women with influenced the results significantly (P Ͻ0.05; P Ͻ0.05). However, when the cut-off was raised to 7.5 mm the outcome was Turner's syndrome. The first pregnancy using a donated oocyte in a hormone replacement cycle was reported in a patient with unaffected. Endometrial echo patterns, whether hypoechoic, isoechoic or hyperechoic, also failed to predict the treatment primary ovarian failure due to ovarian dysgenesis (Lutjen The log likelihood for the models ϭ 92.139 (degrees of freedom ϭ 15* and 16**). The log likelihood for the model ϭ 40.587 (degrees of freedom ϭ 9). et al., 1984) . Since then many series of oocyte donation have tion of embryos and account for the poorer outcome of oocyte donation treatment for Turner's syndrome patients (Hens et al. , included a few cases of Turner's syndrome and reported overall pregnancy rates of~30% per cycle (Rosenwaks 1986; Devroey 1989; Heinze, 1994) . Recently Press et al. (1995) have shown that endometrial thickness and echo pattern before embryo et Salat-Baroux et al., 1988; Abdalla et al., 1989; Cornet et at., 1990) . When compared with patients with transfer were similar in Turner's syndrome and idiopathic ovarian failure patients. The total dose of oestrogen used for secondary ovarian failure, the pregnancy rate following oocyte donation in Turner's syndrome has been reported to be either oocyte donation treatment is much higher than the usual dose required in post-menopausal women for inducing regular higher (Abdalla et al., 1990) or identical (Press et al., 1995) . The pregnancy rate in this study (41.2% per cycle) was withdrawal bleeding. Thus the suboptimum endometrial response on low dose oestrogen replacement as reported by comparable to our earlier experience (50% per cycle) but higher than other reports on oocyte donation for Turner 's Li et al. (1991) can be rectified by a higher dose and longer duration of oestrogen stimulation. This was supported by our syndrome (Heinze, 1994; Press et al., 1995) . As the majority of women had more than one treatment cycle in this series, findings of higher incidence of constant oestrogen regimen, in which a higher dose of oestrogen is used, in the subsequent the improved success rate may be attributable to the option of modification of hormone replacement regimen and mode of cycles when the initial cycles had been less satisfactory. With adequate hormone replacement therapy the development of zygote/embryo transfer in the subsequent cycles from the experiences in the initial treatment cycle.
secretory endometrium confirmed that the uterine receptors are normal and capable of responding to hormone replacement The uterine response to a standard dose of hormone replacement has been reported to be poor in women with Turner's therapy (Cornet et al., 1990) . This view has been confirmed by the satisfactory implantation and pregnancy rates in the syndrome, resulting in smaller uterine thickness, thinner endometrial lining and less advanced endometrial dating compared present study. The total dose of oestrogen replacement before embryo with women with idiopathic ovarian failure (Li et al., 1991) . The suboptimum endometrial response might impair implantatransfer was higher in the pregnant cycles than non-pregnant ones. Since the duration of oestrogen replacement was similar et al., 1993) . It confirms that there is no decline in prognosis with the duration of hypo-oestrogenism that directly correlates in both the pregnant and non-pregnant groups, it was the higher daily dose of a constant regimen, rather than a prolonged with age in primary ovarian failure. There were no differences in the outcome between monosomy and mosaic Turner; the variable regimen, that led to an improved outcome. This finding was in contradiction to a previous report of oocyte latter may have had premature menopause rather than primary amenorrhoea and therefore have a shorter duration of ovarian donation in women with ovarian dysgenesis where successful outcome was limited to the use of a variable dose oestrogen hormone deficiency. The suboptimum endometrial response in Turner's syndrome was thought be dependent on the duration replacement with additional midcycle supplementation (Cornet et al., 1990) . However, the common factor in both the reports and severity of oestrogen deficiency (Davies et al., 1990) . With a uniform treatment outcome irrespective of the age and was a higher total dose of oestradiol in the most effective hormone replacement regimen, be it constant dose or with Turner type in the present study, it seems that a higher total dose of oestrogen replacement can improve the endometrial midcycle supplementation. A higher pregnancy rate was reported in the subsequent cycles probably due to optimal receptivity. The pregnancy rate was unaffected irrespective of the endometrial development since the response to oestrogen in individual woman was already known from the initial attempt.
presence of hypoplastic or bicornuate uteruses and the presence of other associated infertility factors. The improved pregnancy Thus a dummy cycle for monitoring the hormonal response before oocyte donation would be helpful in these patients. The rate reported with tubal rather than uterine transfer in other studies of oocyte donation (Abdalla et al., 1990) has not been benefit of the subsequent cycle was over and beyond the higher total dose of oestrogen in the constant regimen that was demonstrated in the present study. This could be due to the presence of associated hypoplastic tubes that may have more frequently used following previously poor endometrial responses. Individualization of the mode of embryo transfer restricted transfers both mechanically and functionally. However, there may not be any difference in the outcome with from the experience of a previous cycle also played an important role as the route was changed from tubal to uterine different routes of embryo transfer even in individuals with healthy tubes as shown in a prospective study (Balmaceda in six cycles. Our finding was in contrast to another report that has shown a better outcome in the initial cycle followed et al., 1992) . The finding of improved pregnancy rate with fresh rather than frozen-thawed embryo transfer was not by a decline in subsequent cycles (Press et al., 1995) .
In women undergoing oocyte donation for other indications, unexpected as this has also been reported in other studies of oocyte donation (Abdalla et al., 1990; Leeton et al., 1991) . transvaginal sonographic assessment, both before starting progesterone and on the day of embryo transfer, demonstrated
The difference was evident even after correcting for the number of embryos transferred, which are usually fewer in the frozenthicker endometrium in the pregnant cycles in comparison with the non-pregnant ones. The cut-off point for the endometrium as thawed cycles. It was, therefore, the quality of embryo that was responsible for the improved pregnancy rate since the a predictor for the outcome varied considerably between reports, from 7.5 to 10 mm (Check et al., 1993a ; Abdalla higher quality embryos are usually selected for fresh cycles. Another influencing variable for the outcome was the number et al., 1994) . In women with Turner's syndrome the uterus is of a relatively smaller size and it is unreasonable to expect a of oocytes fertilized, independent of the number of embryos transferred although these values are correlated. It indicates that similar endometrial thickness to that of other women. This view was supported by the report that the individual uterine oocyte quality was primarily responsible, as the confounding effects upon fertilizing ability of sperm factor and the number size is the main factor in the development of endometrial thickness in gonadotrophin-stimulated cycles (Strohmer et al., of donor oocytes available, have been eliminated. The functional aspect of oocytes appeared to influence the 1994). In the present study, the outcome of oocyte donation was satisfactory, even with a relatively thinner endometrium, miscarriage rate which was higher in the presence of a low oocyte fertilization rate. The higher miscarriage rate even with and there was no difference in the endometrial thickness between pregnant and non-pregnant cycles. There were pregthe use of donor oocytes suggests that a uterine factor may also be responsible for adverse pregnancy outcome. In women nancies when the endometrial thickness was Ͻ7.5 mm but none was Ͻ6.5 mm, which should be the realistic cut-off point with bicornuate uterus the miscarriage rate was higher. The possibility of uterine anomaly contributing to the high rate of for the Turner's syndrome patients before embryo transfer. Sonographic assessment of endometrial appearance before fetal wastage has been suggested by others but remains debatable (Check et al., 1993b) . The poor pregnancy outcome progesterone replacement was predictive of implantation in donor oocyte recipients in some studies (Shapiro et al., 1993;  in this study was also influenced by the presence of a hypoplastic uterus which may have been associated with Coulam et al., 1994) . However, no significant difference in the pregnancy rate according to the echo pattern was observed uterine anomaly. The presence of a hypoplastic uterus along with hypovascularization has been postulated elsewhere either in the present study or in other reports (Alam et al., 1993; Check et al., 1993a) . (Belercq et al., 1992) as the cause of a higher miscarriage rate. Further studies are therefore required to assess the effect There were no differences in the implantation and pregnancy rates between women with Turner's syndrome of different age of hormone replacement on uterine blood flow in women with Turner's syndrome and its effect on the pregnancy outcome groups. This was in accordance with the unchanged uterine receptivity with age that has been reported among oocyte following oocyte donation.
In conclusion, the outcome of oocyte donation in women recipients (Navot et al., 1991; Sauer et al., 1992; 
